1. Home
  2. TRT vs ATRA Comparison

TRT vs ATRA Comparison

Compare TRT & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trio-Tech International

TRT

Trio-Tech International

HOLD

Current Price

$5.60

Market Cap

35.1M

Sector

Technology

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$4.55

Market Cap

37.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRT
ATRA
Founded
1958
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.1M
37.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
TRT
ATRA
Price
$5.60
$4.55
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
82.3K
717.5K
Earning Date
02-10-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
1.97
Revenue
$42,188,000.00
$151,930,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$163.26
$2.47
Revenue Growth
0.10
51.27
52 Week Low
$2.31
$4.20
52 Week High
$7.60
$19.15

Technical Indicators

Market Signals
Indicator
TRT
ATRA
Relative Strength Index (RSI) 29.61 26.85
Support Level $5.25 $4.91
Resistance Level $6.43 $5.71
Average True Range (ATR) 0.43 0.44
MACD -0.03 0.23
Stochastic Oscillator 6.67 21.85

Price Performance

Historical Comparison
TRT
ATRA

About TRT Trio-Tech International

Trio-Tech International operates in the semiconductor industry, providing manufacturing, testing, and distribution services for semiconductor test equipment and electronic components. It has two main segments: Semiconductor Back-end Solutions (SBS) and Industrial Electronics (IE). The SBS segment, which generates the majority of the Company's revenue, focuses on manufacturing equipment for semiconductor back-end processes, offering testing services, and distributing burn-in test related equipment. The IE segment manufactures equipment for other industries and distributes electronic products outside the semiconductor sector. The Company operates in the United States, Singapore, Malaysia, Thailand, and China, serving customers across multiple regions.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Share on Social Networks: